View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Rheumatoid Arthritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 25, 2022
3 min read
Save

'Waste of energy': One-third of connective tissue disease RCTs never completed, published

'Waste of energy': One-third of connective tissue disease RCTs never completed, published

One out of three registered randomized controlled trials on connective tissue diseases are never completed or published, representing a “waste of energy or resources” that may skew meta-analyses, according to researchers.

SPONSORED CONTENT
January 24, 2022
2 min read
Save

Ultrasound tenosynovitis predicts RA, inflammatory arthritis in suspected arthralgia

Ultrasound tenosynovitis predicts RA, inflammatory arthritis in suspected arthralgia

Tenosynovitis detected through power Doppler ultrasound predicts rheumatoid and inflammatory arthritis development in patients with clinically suspect arthralgia, according to data published in Arthritis Research & Therapy.

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
January 24, 2022
1 min watch
Save

VIDEO: JAK inhibitors have 'transformed' the treatment landscape

VIDEO: JAK inhibitors have 'transformed' the treatment landscape

SPONSORED CONTENT
January 24, 2022
4 min watch
Save

VIDEO: Mitigating risks associated with JAK inhibitor use

VIDEO: Mitigating risks associated with JAK inhibitor use

SPONSORED CONTENT
January 24, 2022
1 min watch
Save

VIDEO: Expert discusses excitement for second-generation JAK inhibitors

VIDEO: Expert discusses excitement for second-generation JAK inhibitors

SPONSORED CONTENT
January 24, 2022
1 min watch
Save

VIDEO: JAK inhibitors show promise in hematologic malignancies, solid tumors

VIDEO: JAK inhibitors show promise in hematologic malignancies, solid tumors

SPONSORED CONTENT
January 20, 2022
2 min read
Save

Biosimilar, originator DMARDs exhibit no differences in treatment retention

Biosimilar, originator DMARDs exhibit no differences in treatment retention

There are no clinically relevant differences in treatment retention among patients receiving biosimilar or originator biologic disease-modifying antirheumatic drugs as first exposure to that drug, data published in Rheumatology show.

SPONSORED CONTENT
January 19, 2022
3 min read
Save

Immune dysfunction linked to 'substantial risk' for breakthrough COVID-19 infection

Immune dysfunction linked to 'substantial risk' for breakthrough COVID-19 infection

Although vaccines reduce the overall risk for COVID-19 regardless of immune status, patients with immune dysfunction are at a “substantial risk” for breakthrough infection versus those without, according to data.

SPONSORED CONTENT
January 18, 2022
3 min read
Save

More than 60% of patients with RA, PsA report side effects in days after methotrexate dose

More than 60% of patients with RA, PsA report side effects in days after methotrexate dose

Approximately 61% of patients with rheumatoid arthritis or psoriatic arthritis who use methotrexate report side effects following weekly dosing, including fatigue and nausea, according to data published in Rheumatology and Therapy.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails